• Je něco špatně v tomto záznamu ?

Toxicokinetic relationship between the adducts in globin and their cleavage products in the urine: Implications for human biomonitoring

J. Mráz, I. Hanzlíková, M. Brabec

. 2024 ; 398 (-) : 82-88. [pub] 20240619

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019871

Globin adducts of various chemicals, persisting in organism over the whole lifetime of erythrocytes, have been used as biomarkers of cumulative exposures to parent compounds. After removal of aged erythrocytes from the bloodstream, cleavage products of these adducts are excreted with urine as alternative, non-invasively accessible biomarkers. In our biomonitoring studies on workers exposed to ethylene oxide, its adduct with globin, N-(2-hydroxyethyl)valine, and the related urinary cleavage product N-(2-hydroxyethyl)-L-valyl-L-leucine have been determined. To describe a toxicokinetic relationship between the above types of biomarkers, a general compartmental model for simulation of formation and removal of globin adducts has been constructed in the form of code in R statistical computing environment. The essential input variables include lifetime of erythrocytes, extent of adduct formation following a single defined exposure, and parameters of exposure scenario, while other possible variables are optional. It was shown that both biomarkers reflect the past exposures differently as the adduct level in globin is a mean value of adduct levels across all compartments (subpopulations of erythrocytes of the same age) while excretion of cleavage products reflects the adduct level in the oldest compartment. Application of the model to various scenarios of continuous exposure demonstrated its usefulness for human biomonitoring data interpretation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019871
003      
CZ-PrNML
005      
20241024111044.0
007      
ta
008      
241015e20240619ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.toxlet.2024.06.007 $2 doi
035    __
$a (PubMed)38906437
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Mráz, Jaroslav $u National Institute of Public Health, Prague, Czech Republic. Electronic address: jaroslav.mraz@szu.cz
245    10
$a Toxicokinetic relationship between the adducts in globin and their cleavage products in the urine: Implications for human biomonitoring / $c J. Mráz, I. Hanzlíková, M. Brabec
520    9_
$a Globin adducts of various chemicals, persisting in organism over the whole lifetime of erythrocytes, have been used as biomarkers of cumulative exposures to parent compounds. After removal of aged erythrocytes from the bloodstream, cleavage products of these adducts are excreted with urine as alternative, non-invasively accessible biomarkers. In our biomonitoring studies on workers exposed to ethylene oxide, its adduct with globin, N-(2-hydroxyethyl)valine, and the related urinary cleavage product N-(2-hydroxyethyl)-L-valyl-L-leucine have been determined. To describe a toxicokinetic relationship between the above types of biomarkers, a general compartmental model for simulation of formation and removal of globin adducts has been constructed in the form of code in R statistical computing environment. The essential input variables include lifetime of erythrocytes, extent of adduct formation following a single defined exposure, and parameters of exposure scenario, while other possible variables are optional. It was shown that both biomarkers reflect the past exposures differently as the adduct level in globin is a mean value of adduct levels across all compartments (subpopulations of erythrocytes of the same age) while excretion of cleavage products reflects the adduct level in the oldest compartment. Application of the model to various scenarios of continuous exposure demonstrated its usefulness for human biomonitoring data interpretation.
650    _2
$a lidé $7 D006801
650    12
$a biologický monitoring $7 D000079687
650    12
$a biologické markery $x moč $x krev $7 D015415
650    12
$a erytrocyty $x metabolismus $x účinky léků $7 D004912
650    12
$a pracovní expozice $7 D016273
650    _2
$a biologické modely $7 D008954
650    _2
$a ethylenoxid $x toxicita $x farmakokinetika $x moč $7 D005027
650    _2
$a toxikokinetika $7 D066007
650    _2
$a globiny $x metabolismus $7 D005914
650    _2
$a valin $x analogy a deriváty $x farmakokinetika $x moč $x krev $7 D014633
650    _2
$a počítačová simulace $7 D003198
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hanzlíková, Iveta $u National Institute of Public Health, Prague, Czech Republic
700    1_
$a Brabec, Marek $u National Institute of Public Health, Prague, Czech Republic; Institute of Computer Science, The Czech Academy of Sciences, Prague, Czech Republic
773    0_
$w MED00004537 $t Toxicology letters $x 1879-3169 $g Roč. 398 (20240619), s. 82-88
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38906437 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111038 $b ABA008
999    __
$a ok $b bmc $g 2202218 $s 1231844
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 398 $c - $d 82-88 $e 20240619 $i 1879-3169 $m Toxicology letters $n Toxicol Lett $x MED00004537
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...